Shares of ACAD are surging this morning. Here's why:
http://www.marketwatch.com/story/acadia-announces-pimavanserin-meets-primary-and-key-secondary-endpoints-in-pivotal-phase-iii-parkinsons-disease-psychosis-trial-2012-11-27
Showing posts with label Pimavanserin. Show all posts
Showing posts with label Pimavanserin. Show all posts
Tuesday, November 27, 2012
Subscribe to:
Posts (Atom)
